chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few weeks after receiving the vaccine I felt light headed, dizzy, fatigue and I had achy muscles and joints in my arms, legs, and back. I discovered bleeding in my ear June 2021. I was sitting and watching tv and then my ear started to itch and it was bleeding. I seen an ENT specialist on June 14th. He removed a blood clot from my ear. He wasn't sure as to why I got a blood clot. The cause is unknown. The ENT doesn't really think that the vaccine caused it. In early August my ENT specialist said I might have difficulty hearing form the ear drops he prescribed because they cause temporary loss. So I have had some loss of hearing. I started breaking out into cold sweats about 3 weeks ago. I have been in and out of hot and humid weather. The fatigue comes and goes. I would be fine sometimes and then all of a sudden I would lose energy. I have an appointment with my cardiologist in September.
Starting 11:45pm on 4/6 woke up with severe chills lasting about 2 hours, severe muscle and bone aches all over body, headache, fever, nausea and dry mouth. All symptoms remained at same intensity for 12 hours and started getting better early afternoon on 4/7. Still had headache and muscle aches until around 6am 4/8.
stomach cramps; diarrhea; chills; This is a spontaneous report from a contactable other healthcare professional. A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) intramuscular at left arm on 24Dec2020 08:00 at single dose for Covid-19 immunization. The COVID-19 vaccine was administered in a hospital facility. Medical history included hypertension, and allergic to penicillin. The patient was not diagnosed with Covid-19 prior vaccination. Concomitant medication included amlodipine and irbesartan; both from unspecified date for unspecified indication. On 26Dec2020 22:30, the patient experienced stomach cramps, diarrhea and chills. The patient was not tested for COVID-19 post vaccination. The patient did not receive treatment due to the events. The outcome of the events stomach cramps, diarrhea and chills was recovering. The reporter considered the events non-serious; the events did not results in death, not life threatening, did not caused/prolonged hospitalization, was not disabling/incapacitating, not a congenital anomaly/birth defect.  Follow-up activities are possible, information on the batch number has been requested.
her energy level went slower; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient) reported for herself. A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Apr2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient got the 1st dose of the Pfizer Covid-19 Vaccine this past Monday (12Apr2021). After getting the vaccine her energy level went slower. She would like to confirm if that reaction is normal. Outcome of events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Post 3rd, 4th dose reported migraine headache, increased irritability and bones hurting. Better each progressive day.
Cellulitis at injection site, redness, swelling, hot to touch, tx w/
testing positive; testing positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EM6205), on 24Mar2021 as dose 2, single (Lot number: ER8727) and on 31Aug2021 as dose 3 (booster), single (Lot number: FC3184) at the age of 31 years for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing); "Dose 1, 2, 3: Pfizer/ Dose 4: Moderna" (unspecified if ongoing), notes: Dose 1, 2, 3: Pfizer/ Dose 4: Moderna. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Mar2022, outcome "unknown" and all described as "testing positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
PATIENT RECEIVED J&J VACCINE FROM MECKLENBURG COUNTY HEALTH DEPARTMENT. HE DID NOT FILL OUT ANY INFOMATION IN VACCINE CONSENT FORM. HE RECIVED PFIZER VACCINE.  HE WANTED TO HAVE MRNA VACCINE ON TOP OF J&J VACCINE.  Pharamcist is reporting duplication of vaccine.
Skin on legs began peeling one week post vaccine. Peeling started at top of thighs and went to shins. One week later, peeling began again in same area in same way. Total time until skin was normal: 3 weeks.
Neck had stiffen up on me terribly; I can't really turn to the left or the right without anything; Pain is getting worse and worse; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 67-year-old female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single, Manufacturer Unknown (Lot Number: Not provided)), for Covid-19 immunisation. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 05Mar2021, outcome "unknown", described as "Neck had stiffen up on me terribly"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 05Mar2021, outcome "unknown", described as "I can't really turn to the left or the right without anything"; PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "Pain is getting worse and worse". Therapeutic measures were taken as a result of musculoskeletal stiffness, joint range of motion decreased, pain.  Additional Information: On 05Mar2021, the patient received second COVID shot and about an hour after, her neck had stiffen up on terribly like she can't really turn to the left or the right without anything and it had been like that since. She reached out to her health provider but she was told to call this number. She wanted to go to the emergency room and wanted to see her medical provider when she called today (date unspecified) because the pain is getting worse and worse. She thought that it will subside when she rested. She took ibuprofen (treatment) but it was getting worse and it was getting tighter.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Less than 24 hours after vaccines: febrile seizure- generalized-1 minute. Coincidental otitis media.
Wife called and stated husband's shoulder was sore and hurt up into his neck.  Thought the shot was given too high.
has had discomfort like a muscle straining feeling and it is continual; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCLE DISCOMFORT (non-serious), outcome "not recovered", described as "has had discomfort like a muscle straining feeling and it is continual".  Additional information: This report is not related to a study or programme. The patient reported that, she was currently driving but was called about the Pfizer Vaccine and was wondered if there were any reports of customers having discomfort in their upper thigh and stated that she had discomfort like a muscle straining feeling and it is continual and wanted to know if there have been any complaints of this. She was not sure if this was due to the vaccine but just knows in the last week or so maybe for 10 days, she had this discomfort and could not say it was related to the vaccine or not but wanted to know if there was any report of this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt. presented w/ feeling light headed and dizzy. Pt moved To Private Treatment area. Pt. history and vitals obtained. Pt. monitored for 30 mins. After approx 22 mins. pT stated she was feeling better. After 30 mins Pt. released and advised to call 911 w/ any further problems.
Pt states he has had pain at injection site since administered on 9/11/14. He reports burning sensation during administration, and achiness in the left deltoid. Pain continues to today.
Patient received vaccine 7/8/15, did not experience any adverse effects until 7/10/15 in the morning. Patient noticed burning and swelling at the injection site, tenderness to touch. Red lump and rash, with spreading infection the size of a softball. Started antibiotics.
Swollen lymph nodes on the left side of lower chin and on the left side of my collar bone.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included BP pills (unspecifed) and bc pills (unspecified) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 25Mar2021 at 08:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 27Apr2021, 12th day post second vaccination, the patient experienced swollen lymph nodes on the left side of her lower chin and on the left side of her collar bone. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes on the left side of her lower chin and on the left side of her collar bone was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
The patient reported that he had severe weakness following the shot, stating that he actually fell down at home on his way back from the bathroom and couldn't move for over an hour.
A report was received from a health care professional on 11/07/03, concerning an 18 month old male vaccinee who inadvertently received Fluvirin on 11/07/03. On 11/07/03 the vaccinee received a single dose of Fluvirin, 0.25ml. At the time of reporting the vaccinee did not exhibit any adverse symptoms. There was insufficient information to determine the reporter's causality assessment. Update 1, 01/07/04: Further information was received from a health care professional on 01/07/04 indicating that the vaccinee did not experience any adverse reaction. No follow up pending, all information received.
I began noticing tinnitus in both ears (high pitched sound) when falling asleep or waking up. I can't point to anything else in my life which could have changed to account for it. I haven't been exposed to more noise than usual. I do feel like my hearing is sensitive currently. Like normal volume on my headphones which hasn't bothered me for the past year now feels like too much sound.
About a month after started with huge canker sores in mouth an fluid filled blisters on face hands head feet has been to Dr 4 or 5 times for this went an allergist an she stated was from chicken pox vaccine an put her on anti viral has gotten At least 40 canker sores in mouth an spots on body took 3 months to figure this out she is still having problems better on antiviral but still showing up with spots.
Rash; Bumps; Itching; Red skin; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (001774).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number unk, Unknown manufacturer.), for COVID-19 Immunization. The following information was reported: RASH (non-serious), outcome "unknown", described as "Rash"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Bumps"; PRURITUS (non-serious), outcome "unknown", described as "Itching"; ERYTHEMA (non-serious), outcome "unknown", described as "Red skin".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Head face and jaw felt swollen like when a dentist administers novalvaine the pain in head and pressure was causing me to lose my cognitive it was very scary I felt near death I talked myself through it kept moving my legs walk-in in place and ate yogurt and drank liquids to stay calm it started dissipating I 20 minutes by 3:30 symptoms subsided to slight headache
Patient went into a vasovagal response with sweating about 8 minutes after the shot. patient came back to consciousness after 7 seconds after pharmacist checked pulse made sure the patient was upright and used applied tension technique. Patient was then given fluids and lime soda that helped the patient come back to total consciousness. We continued to monitor patient for an extra 30 minutes and called family to pick him to ensure that he does not drive. Moreover, I recommended that the patient does not go snowboarding as he was thinking of heading to the mountains today.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2022 at 16:30 as dose 4 (booster), single (Lot number: FK9893) at the age of 65 years, in left arm, on 07Oct2021 at 16:30 as dose 3 (booster), single (Lot number: FF2588), in left arm, on 05Apr2021 at 11:30 as dose 2, single (Lot number: EP7533), in left arm, on 15Mar2021 at 11:30 as dose 1, single (Lot number: EN6208), in left arm and (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "lobster" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Acetaminophen; Guaifenesin.   The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
hospital employee started to have skin rash @ upper back 2-3 hrs p/2nd dose of vax; erythematous skin rash became generalized in 3 days & associated w/itching;
Patient experienced headache, dizziness, light headedness and metallic taste in the mouth a few minutes after receiving the vaccine. Vitals were taken and patient observed for 30 minutes following vaccination.
12/5/21 approximately 4:00 PM patient came to the COVID outreach accompanied by his mother. Patient consent form was checked in and reviewed by employee). The consent form was given to RN who took the form along with the vaccine requested to the vaccinating nurse. Patient a 17-year-old was given a Pfizer COVID 19 booster dose IM in the left deltoid; (previous Pfizer doses were 1/18/2021 and 5/9/2021). Pfizer COVID 19 booster are designated for those 18-year-old and up. Client was monitored for 15 minutes without any adverse reactions or side effects. 12/8/21 9:33AM Attempt a follow up call to patient mother; no answer; left a voice mail message
I had something that I never had in life. Pericardiocentesis. Pericardial effusion. Anti-inflammatories. My heart rate was 180bpm.
No additional adverse effect reported.; Caller reported that PROQUAD that underwent a temperature excursion was administered.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug or allergy history. No concomitant therapies were reported.      On 22-FEB-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T027115 and expiration date since it makes match with the autopopulated expiration date 07-FEB-2022) (dose, route, and anatomical location were not reported) for prophylaxis which was stored at temperature excursion. The vaccinemeasles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was exposed to temperatures between -10 to 8 degrees Celsius during 22 hours, detected by a digital data logger. There was not previous temperature excursion.  No additional adverse effect was reported.
Client states hours after the second vaccine she had a fever, flu like symptoms, headache which resolved by the following day
This spontaneous report was received from a pharmacist via a company representative refers to an 83 year old female patient. No relevant medical history of the patient was reported. It was reported that the patient was vaccinated with 3 doses of PNEUMOVAX 23 (strength, lot number and expiration date were not reported), over an unspecified time frame. There were no concomitant therapies reported. There were no adverse effects reported. There was no product quality complaint (PQC) involved. The outcome of received 3 doses of PNEUNOVAX 23 over an unspecified time frame was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
pt received covid shot and was waiting her 15 minutes. about 5 minutes later she fainted and an ambulance was called and took her to the hospital.
Hives began to appear on my face and body. They still continue as of 1/7. I am taking methylprednisol, Zyrtec and Pepcid
dizzy; her heart was racing; a little SOB; throwing up; exhausted; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration on 20Apr2021 (at the age of 39-year-old) as dose 1, single for COVID-19 immunization. Medical history included severe anxiety. The concomitant medications were not reported. The patient experienced dizzy, her heart was racing, which made her a little short of breath, an episode of dizziness and throwing up on 20Apr2021. That evening she had an episode of dizziness and throwing up. She was exhausted for a week. She went up to the health department to get her second dose 21 days later and the health department wouldn't let her get the second vaccine and they said it was a severe reaction, and she was not allowed to get the second dose. She did start a masters program in nursing. So she had to get vaccines for it. This upcoming Tuesday would be 2 weeks. She got the MMR and Varicella vaccine on 24Aug2021. She enquired if she need to wait a solid two weeks before getting the second dose of the Pfizer Covid 19 vaccine. After the vaccine she had a reaction and she was unsure if it was anxiety or a true reaction. With the new Delta Variant, she wanted the second dose. She asked if Pfizer thought that was a severe reaction and asked if it was still okay to get the second dose because of the time lapse since the first dose. She was not immune to varicella chicken pox. The outcome of the events was unknown.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse practitioner concerning a female patient who on an unspecified date was vaccinated with the first dose of GARDASIL (lot #, route and site of administration not reported). It was reported that the patient passed out right after receiving the first vaccination and then the patient was able to leave the office. At the time of this report, the patient had recovered. The reporter felt that passed out was not related to therapy with GARDASIL. The reporter and the patient's mother feel the experience may have occurred because the patient was anxious before receiving the vaccination. The patient was going to receive second dose of GARDASIL. Additional information has been requested.
This case was reported by a physician via call center representative and described the occurrence of diarrhea in a 87-year-old male patient who received SHINGRIX for prophylaxis. On 5th March 2019, the patient received the 1st dose of SHINGRIX. On 8th March 2019, 3 days after receiving SHINGRIX, the patient experienced diarrhea and fecal incontinence. On an unknown date, the outcome of the diarrhea and fecal incontinence were unknown. It was unknown if the reporter considered the diarrhea and fecal incontinence to be related to SHINGRIX. Additional details were provided as follows: The patient reported that he received the vaccine on the left arm, and 72 hours later experienced severe diarrhea. The patient was driving on the reporting date and lost control of his bowels. The reporter gave consent to follow up. This case has been linked to the case US2019042996 reported by same reporter.